Press Releases - Oncology

Press Releases - Oncology

January 10, 2019
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development
November 07, 2018
Launching Test Bed for up to 10-plex assays with Simoa Sensitivity and Specificity to Advance Cancer Research
October 22, 2018
Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection
CAMBRIDGE, MA – May 23, 2010 – Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company’s proprietary technology that demonstrates an unprecedented sensitivity…
CAMBRIDGE, MA – October 13, 2011 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, today announced results from a clinical evaluation of its Prostate Specific Antigen (PSA) test, a fifth–…
DENVER – A new test could reliably detect early increases in prostate specific antigen (PSA) levels – a biomarker commonly used to measure the recurrence of prostate cancer – in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with…

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more